Perk Pharmaceuticals
No trades in 1Y
Key Insights
Strengths
2- Company has reduced debt.
- Company is almost debt free.
Weaknesses
4- The company has delivered a poor sales growth of 1.20% over past five years.
- Company has a low return on equity of 2.58% over last 3 years.
- Company has high debtors of 588 days.
- Company's cost of borrowing seems high
Growth Rate
Annual windows: The latest annual results are more than two years old, so no annual growth is shown.
Trailing twelve months: No quarterly results are reported.
Not shown: Quarterly Results. Not this company's figures: left behind by an earlier update and not confirmed by the latest one.
Profit & Loss
₹ Cr| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 |
|---|---|---|---|---|---|---|
| Sales | 1.14 | 1.42 | 1.3 | 1.4 | 1.32 | 1.21 |
| Expenses | 1.64 | 1.14 | 1.43 | 1.2 | 0.81 | 0.97 |
| Operating Profit | −0.5 | 0.28 | −0.13 | 0.2 | 0.51 | 0.24 |
| OPM % | −43.86% | 19.72% | −10% | 14.29% | 38.64% | 19.83% |
| Other Income | 0 | 0 | 0.01 | 0 | 0 | 0 |
| Interest | 0.04 | 0.05 | 0.02 | 0.03 | 0.04 | 0.03 |
| Depreciation | 0.14 | 0.13 | 0.16 | 0.15 | 0.14 | 0.14 |
| PBT | −0.68 | 0.1 | −0.3 | 0.02 | 0.33 | 0.07 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | −0.68 | 0.1 | −0.3 | 0.02 | 0.33 | 0.07 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 |
|---|---|---|---|---|---|---|
| Equity Capital | 6.38 | 6.38 | 6.38 | 6.38 | 6.38 | 6.38 |
| Reserves | −2.61 | −0.85 | −1.15 | −1.13 | −0.79 | −0.72 |
| Borrowings | 0.47 | 0.35 | 0.46 | 0.33 | 0.27 | 0.02 |
| Other Liabilities | 1.07 | 0.99 | 0.85 | 0.42 | 0.85 | 1.4 |
| Total Liabilities | 5.31 | 6.87 | 6.54 | 6 | 6.71 | 7.08 |
| Fixed Assets | 2.87 | 4.39 | 4.17 | 4.02 | 3.88 | 3.82 |
| CWIP | 0.08 | 0.08 | 0.1 | 0.1 | 0.1 | 0.1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 2.36 | 2.4 | 2.27 | 1.88 | 2.73 | 3.16 |
| Total Assets | 5.31 | 6.87 | 6.54 | 6 | 6.71 | 7.08 |
Cash Flow
₹ Cr| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 |
|---|---|---|---|---|---|---|
| Operating | 0.02 | 0.15 | 0.03 | −0.08 | 0.05 | 0.58 |
| Investing | −0.03 | −0.01 | 0.03 | 0 | 0 | −0.08 |
| Financing | 0.01 | −0.12 | 0.11 | −0.13 | −0.05 | −0.25 |
| Net Cash Flow | 0 | 0.02 | 0.17 | −0.21 | 0 | 0.25 |
| Free Cash Flow | −0.01 | 0.14 | 0.06 | −0.08 | 0.05 | 0.5 |
| CFO/OP | −4 | 54 | −23 | −40 | 10 | 242 |
Ratios
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 |
|---|---|---|---|---|---|---|
| Debtor Days | 106 | 139 | 168 | 224 | 462 | 588 |
| Inventory Days | 471 | 849 | 386 | 419 | 730 | 557 |
| Days Payable | 118 | 225 | 153 | 150 | 344 | 767 |
| Cash Conversion Cycle | 459 | 764 | 401 | 493 | 848 | 378 |
| Working Capital Days | 362 | 324 | 314 | 362 | 503 | 437 |
| ROCE % | — | 2.96% | −4.84% | 0.89% | 6.47% | 1.73% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Perk Pharmaceuticals insights
29 extracted metrics across FY06–FY26.
Documents
- 2 Feb 2026
- 28 Jan 2026
- 16 Jan 2026
Frequently Asked Questions about Perk Pharmaceuticals
What does Perk Pharmaceuticals Ltd do?
Where is Perk Pharmaceuticals Ltd (530673) listed?
Which sector does Perk Pharmaceuticals Ltd belong to?
Company Information
Perk Pharmaceuticals Ltd. engages in manufactures and markets specialty pharmaceuticals.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/530673.md for Perk Pharmaceuticals Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.